NASDAQ: ANIK
Anika Therapeutics Inc Stock Ownership - Who owns Anika Therapeutics?

Insider buying vs selling

Have Anika Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Stephen D. GriffinEVP CFO COO2025-06-033,769$11.59
$43.68kSell
Cheryl R. BlanchardPresident CEO Director2025-03-1712,152$15.91
$193.34kSell
Anne NunesSVP Chief Operations Officer2025-03-171,068$15.91
$16.99kSell
David ColleranEVP General Counsel Corp Sec2025-03-171,893$15.91
$30.12kSell
Cheryl R. BlanchardPresident CEO Director2025-03-1112,675$16.79
$212.81kSell
David ColleranEVP General Counsel Corp Sec2025-03-112,250$16.79
$37.78kSell
Anne NunesSVP Chief Operations Officer2025-03-11752$16.79
$12.63kSell
David ColleranEVP General Counsel Corp Sec2025-03-101,604$16.62
$26.66kSell
Cheryl R. BlanchardPresident CEO Director2025-03-105,871$16.62
$97.58kSell
Anne NunesSVP Chief Operations Officer2025-03-10959$16.62
$15.94kSell

1 of 2

ANIK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANIK insiders and whales buy or sell their stock.

ANIK Shareholders

What type of owners hold Anika Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Trigran Investments Inc14.24%2,041,853$22.42MInstitution
Blackrock Inc10.59%1,519,261$16.68MInstitution
Caligan Partners LP10.01%1,435,130$15.76MInstitution
Farmaceutici Spa Fidia9.92%1,422,384$15.62MInsider
Vanguard Group Inc5.42%777,405$8.54MInstitution
Dimensional Fund Advisors LP4.28%613,972$6.74MInstitution
Acadian Asset Management LLC3.76%539,614$5.92MInstitution
Boothbay Fund Management LLC3.69%529,503$5.81MInstitution
Renaissance Technologies LLC3.69%528,617$5.80MInstitution
Alta Fundamental Advisers LLC3.28%470,974$5.17MInstitution

1 of 3

ANIK vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANIK82.63%17.37%Net SellingNet Selling
LNSR33.90%51.31%Net Buying
RPID33.09%66.91%Net Buying
RCEL26.65%3.82%Net BuyingNet Buying
ELMD29.93%70.07%Net Selling

Anika Therapeutics Stock Ownership FAQ

Who owns Anika Therapeutics?

Anika Therapeutics (NASDAQ: ANIK) is owned by 88.40% institutional shareholders, 18.58% Anika Therapeutics insiders, and 0.00% retail investors. Farmaceutici Spa Fidia is the largest individual Anika Therapeutics shareholder, owning 1.42M shares representing 9.92% of the company. Farmaceutici Spa Fidia's Anika Therapeutics shares are currently valued at $15.85M.

If you're new to stock investing, here's how to buy Anika Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.